Pick of the Week - Aurobindo Pharma Ltd - 04 MAR 2024
The company is engaged in the development, manufacturing, and commercialization of a wide range of generic pharmaceuticals, branded specialty...
291 Views
HSIE Results Daily: Shree Cement, Aurobindo Pharma, Gujarat State Petronet
During Q2FY25, Shree volume declined 7% YoY as it focused on trade sales while non-trade demand was weak. Cement NSR fell only 0.4% QoQ, lower vs...
164 Views
Axis Top Picks for the Month of November 2024
The Axis Top Picks Basket delivered a return of 11.6% in the last six months against the 7.5% returns posted by Nifty 50 over the same period.
168 Views
Pharma and Healthcare (Q2FY25E Results Preview): Steady Q2, Revlimid to Normalise
The India Pharma & Healthcare sector is expected to maintain its growth momentum in Q2FY25E. We project sales/EBITDA growth of 11%/15% YoY for our...
201 Views
Q2FY25 Earnings Preview - Pharma
We anticipate that the pharmaceutical companies within our coverage will collectively demonstrate revenue growth of 8.5% YoY and 3.1% QoQ, along...
193 Views